SIGA Technologies

February 17, 2020

Solving the mystery of Vifor’s new voucher

August 22, 2019

Astra could use a voucher to cement roxadustat’s head start

Spending $95m to speed up the anaemia project’s path to approval could be worth the investment for Astrazeneca.

January 15, 2019

Topping 2018 drug approvals will be a tall order

Was 2018 as good as it gets for drug approvals, or is the pipeline so stellar that even a US government shutdown cannot stop biopharma?

October 04, 2011

Pharmasset continues to lead small cap gainers so far in 2011

August 11, 2011

Vantage Point - Biotech partners force shifts in US biosecurity funding

February 22, 2011

Therapeutic focus – Growing dengue pandemic highlights limited treatment pipeline

January 07, 2011

Comeback stories drive small cap risers in 2010

July 03, 2009

Generics still doing well amongst small-caps in first half

April 02, 2009

InterMune tops small cap gainers in first quarter of 2009

October 30, 2008

Big Pharma hunting for bargains have plenty of choice